(19)
(11)
EP 1 244 686 A1
(12)
(43)
Date of publication:
02.10.2002
Bulletin 2002/40
(21)
Application number:
00983862.4
(22)
Date of filing:
01.12.2000
(51)
International Patent Classification (IPC)
7
:
C07H
21/04
,
C12N
1/21
,
C12N
15/00
,
C12P
21/00
,
C07K
14/495
,
C07K
16/22
,
A61K
38/18
,
A61K
48/00
,
C12Q
1/68
,
G01N
33/53
(86)
International application number:
PCT/US0032/745
(87)
International publication number:
WO 0104/0251
(
07.06.2001
Gazette 2001/23)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
02.12.1999
US 168387 P
(71)
Applicant:
Human Genome Sciences, Inc.
Rockville, MD 20850 (US)
(72)
Inventor:
WEI, Ying-Fei
Berkeley, CA 94705 (US)
(74)
Representative:
VOSSIUS & PARTNER
Siebertstrasse 4
81675 München
81675 München (DE)
(54)
TRANSFORMING GROWTH FACTOR ALPHA HIII